Treace to Present at Truist Securities MedTech Conference

Core Insights - Treace Medical Concepts, Inc. is participating in a fireside chat at the Truist Securities MedTech Conference on June 18, 2024, featuring CEO John T. Treace and CFO Mark L. Hair [1] Company Overview - Treace Medical Concepts is focused on advancing surgical treatment for bunions and related midfoot deformities, with its flagship procedures being Lapiplasty® and Adductoplasty® [4] - Approximately 67 million Americans are affected by bunions, with an estimated 1.1 million being annual surgical candidates [4] - The company has developed the Lapiplasty® 3D Bunion Correction® System, which addresses the root cause of bunions by correcting deformities in all three planes and stabilizing the affected joint [4] - Treace has also introduced the Adductoplasty® Midfoot Correction System and the Hammertoe PEEK Fixation System to address various foot deformities [4] - The company is expanding its product offerings with the SpeedPlate™ Rapid Compression Implants, which provide versatile fixation options for various surgical procedures [4]